Copyright
©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1226-1233
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1226
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1226
Table 1 Comparison of patients’ general data
Research (n = 65) | Control (n = 60) | t/χ2 | P value | 95%CI | |
Sex (male/female) | 39/26 | 40/20 | 0.5962 | 0.4400 | 0.3610 to 1.5580 |
Average age (yr) | 64.66 ± 5.45 | 66.63 ± 6.15 | 1.6132 | 0.1093 | -0.3856 to 3.8370 |
BMI (kg/m2) | 22.39 ± 1.75 | 22.91 ± 1.84 | 1.6193 | 0.7079 | -0.1081 to 1.1630 |
Course of diabetes mellitus (yr) | 10.58 ± 1.95 | 10.68 ± 2.74 | 0.2365 | 0.8135 | -1.1820 to 2.2130 |
NYHA grading of cardiac function | 125.03 | < 0.0001 | |||
I | 0 | 60 | |||
II | 19 | 0 | |||
III | 25 | 0 | |||
IV | 21 | 0 | |||
History of hypertension | 30 | 25 | 0.2550 | 0.6136 | 0.5911 to 2.4360 |
Smoking history | 32 | 23 | 1.5041 | 0.2201 | 0.7651 to 3.181 |
Table 2 Neutrophil-lymphocyte ratio and red blood cell distribution width levels in two groups
NLR | RDW | LVEF (%) | |
Research (n = 65) | 5.40 ± 1.79 | 16.00 ± 1.63 | 41.85 ± 7.23 |
Control (n = 60) | 2.99 ± 0.98 | 13.88 ± 1.08 | 58.07 ± 6.79 |
t | 9.2283 | 8.4976 | 12.9016 |
P value | < 0.0001 | < 0.0001 | < 0.0001 |
95%CI | -2.921 to -1.889 | -2.619 to -1.629 | 13.73 to 18.71 |
Table 3 Comparison of general data in research groups with different cardiac function grades
NYHA classification | n | Male | Age (mean ± SD) | Course of diabetes mellitus | NLR | RDW | LEVF (%) |
II | 19 | 8 | 62.79 ± 4.83 | 10.77 ± 1.83 | 3.91 ± 1.64 | 14.72 ± 1.25 | 45.82 ± 6.14 |
III | 25 | 16 | 65.84 ± 5.81 | 10.30 ± 1.96 | 5.55 ± 1.31 | 15.53 ± 1.04 | 42.75 ± 5.94 |
IV | 21 | 15 | 65.71 ± 6.25 | 10.75 ± 2.11 | 6.56 ± 1.48 | 17.72 ± 0.93 | 37.20 ± 7.23 |
F | 3.8452 | 1.8600 | 0.4070 | 16.4300 | 42.7900 | 9.3240 | |
P value | 0.1463 | 0.1643 | 0.6674 | < 0.0001 | < 0.0001 | 0.0003 |
Table 4 Diagnostic efficiency of neutrophil-lymphocyte ratio and red blood cell distribution width
AUC | SE | Specificity (%) | Sensitivity (%) | 95%CI | |
NLR | 0.864 | 0.033 | 90.0 | 75.4 | 0.799-0.929 |
RDW | 0.859 | 0.034 | 86.7 | 76.9 | 0.793-0.925 |
Joint detection | 0.915 | 0.027 | 100.0 | 76.9 | 0.863-0.968 |
Table 5 Comparison of neutrophil-lymphocyte ratio and red blood cell distribution width levels in patients with or without cardiac events
n | NLR | RDW | |
Without cardiac events | 46 | 4.97 ± 1.66 | 15.70 ± 1.64 |
With cardiac events | 19 | 6.45 ± .68 | 16.72 ± 1.42 |
t | 3.2610 | 2.3540 | |
P value | 0.0018 | 0.0217 |
- Citation: Pang J, Qian LY, Lv P, Che XR. Application of neutrophil-lymphocyte ratio and red blood cell distribution width in diabetes mellitus complicated with heart failure. World J Diabetes 2024; 15(6): 1226-1233
- URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1226.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1226